Cargando…
Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer
Colorectal cancer is considered one of the major malignancies that threaten the lives and health of people around the world. Patients with CRC are prone to post-operative local recurrence or metastasis, and some patients are advanced at the time of diagnosis and have no chance for complete surgical...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367166/ https://www.ncbi.nlm.nih.gov/pubmed/35953863 http://dx.doi.org/10.1186/s12951-022-01586-4 |
_version_ | 1784765727397380096 |
---|---|
author | Guo, Yu Wang, Min Zou, Yongbo Jin, Longhai Zhao, Zeyun Liu, Qi Wang, Shuang Li, Jiannan |
author_facet | Guo, Yu Wang, Min Zou, Yongbo Jin, Longhai Zhao, Zeyun Liu, Qi Wang, Shuang Li, Jiannan |
author_sort | Guo, Yu |
collection | PubMed |
description | Colorectal cancer is considered one of the major malignancies that threaten the lives and health of people around the world. Patients with CRC are prone to post-operative local recurrence or metastasis, and some patients are advanced at the time of diagnosis and have no chance for complete surgical resection. These factors make chemotherapy an indispensable and important tool in treating CRC. However, the complex composition of the tumor microenvironment and the interaction of cellular and interstitial components constitute a tumor tissue with high cell density, dense extracellular matrix, and high osmotic pressure, inevitably preventing chemotherapeutic drugs from entering and acting on tumor cells. As a result, a novel drug carrier system with targeted nanoparticles has been applied to tumor therapy. It can change the physicochemical properties of drugs, facilitate the crossing of drug molecules through physiological and pathological tissue barriers, and increase the local concentration of nanomedicines at lesion sites. In addition to improving drug efficacy, targeted nanoparticles also reduce side effects, enabling safer and more effective disease diagnosis and treatment and improving bioavailability. In this review, we discuss the mechanisms by which infiltrating cells and other stromal components of the tumor microenvironment comprise barriers to chemotherapy in colorectal cancer. The research and application of targeted nanoparticles in CRC treatment are also classified. |
format | Online Article Text |
id | pubmed-9367166 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93671662022-08-12 Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer Guo, Yu Wang, Min Zou, Yongbo Jin, Longhai Zhao, Zeyun Liu, Qi Wang, Shuang Li, Jiannan J Nanobiotechnology Review Colorectal cancer is considered one of the major malignancies that threaten the lives and health of people around the world. Patients with CRC are prone to post-operative local recurrence or metastasis, and some patients are advanced at the time of diagnosis and have no chance for complete surgical resection. These factors make chemotherapy an indispensable and important tool in treating CRC. However, the complex composition of the tumor microenvironment and the interaction of cellular and interstitial components constitute a tumor tissue with high cell density, dense extracellular matrix, and high osmotic pressure, inevitably preventing chemotherapeutic drugs from entering and acting on tumor cells. As a result, a novel drug carrier system with targeted nanoparticles has been applied to tumor therapy. It can change the physicochemical properties of drugs, facilitate the crossing of drug molecules through physiological and pathological tissue barriers, and increase the local concentration of nanomedicines at lesion sites. In addition to improving drug efficacy, targeted nanoparticles also reduce side effects, enabling safer and more effective disease diagnosis and treatment and improving bioavailability. In this review, we discuss the mechanisms by which infiltrating cells and other stromal components of the tumor microenvironment comprise barriers to chemotherapy in colorectal cancer. The research and application of targeted nanoparticles in CRC treatment are also classified. BioMed Central 2022-08-11 /pmc/articles/PMC9367166/ /pubmed/35953863 http://dx.doi.org/10.1186/s12951-022-01586-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Guo, Yu Wang, Min Zou, Yongbo Jin, Longhai Zhao, Zeyun Liu, Qi Wang, Shuang Li, Jiannan Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer |
title | Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer |
title_full | Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer |
title_fullStr | Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer |
title_full_unstemmed | Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer |
title_short | Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer |
title_sort | mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367166/ https://www.ncbi.nlm.nih.gov/pubmed/35953863 http://dx.doi.org/10.1186/s12951-022-01586-4 |
work_keys_str_mv | AT guoyu mechanismsofchemotherapeuticresistanceandtheapplicationoftargetednanoparticlesforenhancedchemotherapyincolorectalcancer AT wangmin mechanismsofchemotherapeuticresistanceandtheapplicationoftargetednanoparticlesforenhancedchemotherapyincolorectalcancer AT zouyongbo mechanismsofchemotherapeuticresistanceandtheapplicationoftargetednanoparticlesforenhancedchemotherapyincolorectalcancer AT jinlonghai mechanismsofchemotherapeuticresistanceandtheapplicationoftargetednanoparticlesforenhancedchemotherapyincolorectalcancer AT zhaozeyun mechanismsofchemotherapeuticresistanceandtheapplicationoftargetednanoparticlesforenhancedchemotherapyincolorectalcancer AT liuqi mechanismsofchemotherapeuticresistanceandtheapplicationoftargetednanoparticlesforenhancedchemotherapyincolorectalcancer AT wangshuang mechanismsofchemotherapeuticresistanceandtheapplicationoftargetednanoparticlesforenhancedchemotherapyincolorectalcancer AT lijiannan mechanismsofchemotherapeuticresistanceandtheapplicationoftargetednanoparticlesforenhancedchemotherapyincolorectalcancer |